ReviewFrontiers in endocrinology2022

Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies.

David Standing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.